Clinical Trials Logo

GERD clinical trials

View clinical trials related to GERD.

Filter by:

NCT ID: NCT04422405 Recruiting - Obesity, Morbid Clinical Trials

Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGB

BiFLux
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Evaluation of the functional changes in the stomach and esophagus of patients undergoing One Anastomosis Gastric Bypass (OAGB)

NCT ID: NCT04360252 Recruiting - Clinical trials for Gastroesophageal Reflux

Gracie Diet for Gastroesophageal Reflux Disease

Start date: November 13, 2020
Phase: N/A
Study type: Interventional

GERD, is a common and chronic world-wide disease. Cardinal symptoms of this condition are heartburn-regurgitation, and sometimes with extra-intestinal symptoms that can affect patients' quality of life. Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for treatment of acid-related diseases. This class of medications is the most widely used for the management of GERD. H2 Receptor Antagonists (H2RAs) are another type of medication used to of uncomplicated GERD, gastric or duodenal ulcers, gastric hypersecretion, and for mild to infrequent heartburn or indigestion. H2RAs decrease gastric acid secretion by reversibly binding to histamine H2 receptors located on gastric parietal cells, thereby inhibiting the binding and action of the endogenous ligand histamine. Dietary modification is endorsed by the National Institutes of Health and the American College of Gastroenterology as a first-line therapy for patients with GERD. The Gracie Diet is thought to play an important role in the prevention of GERD. The concept behind this diet is that the consumption of proper food combinations promotes optimal health by preventing unhealthy chemical reactions in the digestive process such as fermentation and acidity. This diet describes the benefits of combining different foods together and the downsides of combining others. It provides guidance on avoiding specific foods and combinations of foods that may aggravate GERD, and adopting meal spacing habits to improve overall health outcomes. The idea is that such dietary changes support more efficient digestion and encourage healthier lifestyles (i.e. smoking cessation, elimination of alcohol intake, avoidance of soda consumption and desserts). This diet also supports the acquisition of healthy eating habits characterized by higher consumption of fruits, vegetables, and whole grains, and encourages a reduction in the intake of saturated fat, sodium, added sugars, and canned foods. Limiting beverage consumption of water or fresh coconut water between meals is also encouraged. In this pilot study, the investigators hypothesized that the Gracie diet it could be an alternative option to improve GERD symptoms in those patients who do not respond to standard doses of PPI and/or H2 receptor antagonists.

NCT ID: NCT04358146 Not yet recruiting - Clinical trials for Gastroesophageal Reflux in Children

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)

STELLAR
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized, controlled, double-blind trial against a comparator.

NCT ID: NCT04301986 Completed - GERD Clinical Trials

Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus

Start date: August 11, 2020
Phase: N/A
Study type: Interventional

To assess patient acceptance and preference among screening modalities, Esophagogastroduodenoscopy (EGD), Transnasal Esophagoscopy (TNE), and Cytosponge for Barrett's esophagus (BE). Subjects will undergo administration of Cytosponge and transnasal endoscopy (TNE) prior to their scheduled clinically indicated upper endoscopy performed per routine standard of care. Following the procedure, a follow-up phone call will be made during which an impact of events scale related to the subjective distress of each procedure, a preference and acceptance questionnaire, and adverse events related to study participation will be collected.

NCT ID: NCT04294823 Withdrawn - GERD Clinical Trials

Sensitivity and Specificity of the Modified Helicobacter Test INFAI

Start date: November 2020
Phase:
Study type: Observational

Study to confirm the sensitivity of the C^13-UBT using the new test meal for H. Pylori in patients with dyspepsia and GERD taking PPI Secondary objectives : to compare the sensitivity and specificity of the C^13-UBT using the new test meal and standard test meal for H.Pylori in patients with dyspepsia and GERD taking PPI. to complete the results of the Helicbacter test INFAI using new test meal for H.Pylori in patients with dyspepsia and GERD taking PPI with : - Histology score for H.Pylori in antrum an corpus using the updated Sydney System - Sex, - Age, - Body Mass Index (BMI)

NCT ID: NCT04293107 Recruiting - Quality of Life Clinical Trials

Gastro-oesophageal Reflux and NeuroDisability (Cerebral Palsy) in CHILDren

GRANDCHILD
Start date: January 22, 2021
Phase:
Study type: Observational

This study assesses the content validity of the PGSQ for parents/carer of children with cerebral palsy and GORD, including features such as readability, face validity and acceptability for completion. This will be done via 6 interviews, with the PGSQ being altered as identified as required. Reliability (test-retest) of the adapted version of the PGSQ being assessed with a sample of 20 parents/carers.

NCT ID: NCT04292470 Completed - GERD Clinical Trials

Physiology of GERD and Treatment Response

Start date: November 5, 2020
Phase: N/A
Study type: Interventional

This study is designed to assess the physiologic and behavioral mechanisms associated with enhanced medication effects in adult patients with functional GERD-related symptoms.

NCT ID: NCT04282954 Completed - GERD Clinical Trials

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

Start date: November 15, 2019
Phase: Phase 2
Study type: Interventional

Clinical trial to evaluate the safety and efficacy of JP-1366 in patients with erosive gastroesophageal reflux disease

NCT ID: NCT04255693 Recruiting - Clinical trials for Gastroesophageal Reflux Disease

Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence

Start date: January 31, 2020
Phase: N/A
Study type: Interventional

This study is aimed to investigate the role of long-term diet adherence on manifestations of gastroesophageal reflux disease

NCT ID: NCT04252144 Recruiting - Clinical trials for Gastroesophageal Reflux

Study of Dietary Patterns and Food Diversity in Russian GERD Patients

Start date: January 30, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to assess food diversity and dietary patterns in Russian GERD patients